ASD vs PSIL
Defiance Autism Impact ETF against AdvisorShares Psychedelics ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
13%
4 shared positions
Fee gap
21 bp
ASD is cheaper
1-year return gap
—
Larger fund
PSIL
$49M
Side by side
| ASD | PSIL | |
|---|---|---|
| Fund | Defiance Autism Impact ETF | AdvisorShares Psychedelics ETF |
| Issuer | Defiance | AdvisorShares |
| Category | ESG & Values | Cannabis |
| Expense ratio | 0.79% | 1.00% |
| Assets | $1.4M | $49M |
| Average daily dollar volume | $7K | $807K |
| Listed | Jun 1, 2026 | Sep 15, 2021 |
| FrenzyCap score | 16 | 20 |
| 1-month return | −1.2% | −11.9% |
| 3-month return | −1.4% | −6.3% |
| Year to date | — | +26.8% |
| 1-year return | — | +6.3% |
| 30-day volatility | 12.1% | 27.4% |
| Worst drawdown, 1 year | −7.7% | −27.6% |
| Trailing 12-month yield | 0.03% | 7.74% |
| Holdings | 39 | 32 |
| Top 10 weight | 30.8% | 69.2% |
| Look-through P/E | — | — |
| Holdings vs fair value | +17.6% | +1.9% |
| Holdings above 200-day average | 55% | 51% |
| Net flow, latest 3 reported months | +$1.3M thru Jun 2026 | +$14M thru Jun 2026 |
| 30-day implied volatility | — | 49.9% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Jun 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
13% of ASD · 23% of PSIL
Sector mix of the stock holdings
| Sector | ASD | PSIL | Gap |
|---|---|---|---|
| Health Care | 46.8% | 86.8% | −40.0% |
| Consumer Discretionary | 6.8% | 0.0% | +6.8% |
| Technology | 2.7% | 0.0% | +2.7% |
| Other | 2.7% | 0.0% | +2.7% |
More: full overlap table · ASD holdings · PSIL holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.